Clinical trial
Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00003446 · Grupo Oncologico Cooperativo del Sur, Other · Completed
Key facts
| NCT number | NCT00003446 |
|---|---|
| Title | Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer |
| Official title | Phase II Trial of Trimetrexate (Neutrexin), 5-Fluorouracil and Leucovorin in Metastatic Colorectal Cancer |
| Lead sponsor | Grupo Oncologico Cooperativo del Sur, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, leucovorin calcium, trimetrexate glucuronate |
| Start date | Dec 1, 1997 |
| Completion | Aug 1, 2005 |
| First posted | Apr 9, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: